SEC Info - Bio Key International Inc.

SEC Info℠

Home

Help

Please Sign In

Bio Key International Inc. – ‘8-K’ for 4/1/24

On: Tuesday, 4/2/24, at 8:30am ET · For: 4/1/24 · Accession #: 1437749-24-10505 · File #: 1-13463

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/02/24  Bio Key International Inc.        8-K:2,9     4/01/24   12:188K                                   RDG Filings/FA

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     26K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     21K 
 7: R1          Document And Entity Information                     HTML     46K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
12: XML         XBRL Instance -- bkyi20240401_8k_htm                 XML     14K 
 8: EXCEL       IDEA Workbook of Financial Report Info              XLSX      8K 
 4: EX-101.DEF  XBRL Definitions -- bkyi-20240401_def                XML     37K 
 5: EX-101.LAB  XBRL Labels -- bkyi-20240401_lab                     XML     47K 
 6: EX-101.PRE  XBRL Presentations -- bkyi-20240401_pre              XML     36K 
 3: EX-101.SCH  XBRL Schema -- bkyi-20240401                         XSD     14K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
11: ZIP         XBRL Zipped Folder -- 0001437749-24-010505-xbrl      Zip     21K

‘8-K’ — Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C:

i false i 0001019034 0001019034 2024-04-01 2024-04-01

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): i April 1, 2024

i BIO-key International, Inc. (Exact name of registrant as specified in its charter)

i Delaware (State or other jurisdiction of incorporation)	i 1-13463 (Commission File Number)	i 41-1741861 (I.R.S. Employer Identification No.)

i 101 Crawfords Corner Road, Suite 4116 i Holmdel, i NJ i 07733 (Address of principal executive offices)

( i 732) i 359-1100 (Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
i Common Stock	i BKYI	i Nasdaq Capital market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

i ☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ☐	Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02.

Results of Operations and Financial Condition.

On April 1, 2024 BIO-key International, Inc. (the “Company”) issued a press release announcing its financial results for its fourth quarter and year ended December 31, 2023. A copy of the press release issued by the Company on April 1, 2024 is attached as Exhibit 99.

The information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.

Item 9.01.

Financial Statements, Pro Forma Financial Information and Exhibit.

(d)	Exhibits. The following exhibit is furnished herewith:

99.1	Press Release, dated April 1, 2024 issued by the Company.

104	Cover Page Interactive Data File (embedded with the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	BIO-KEY INTERNATIONAL, INC.
Date: April 2, 2024

	By:	/s/ *Cecilia C. Welch*
		Cecilia C. Welch
		Chief Financial Officer

EXHIBIT INDEX

Exhibit No.	Description

99.1	Press Release, dated April 1, 2024 issued by the Company.

Dates Referenced Herein and Documents Incorporated by Reference

This ‘8-K’ Filing	Date	Other Filings

Filed on:	4/2/24	None on these Dates
For Period end:	4/1/24
	12/31/23
		List all Filings

↑Top

Filing Submission 0001437749-24-010505 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)